
You need advice on which endpoints to choose, which technologies and biomarkers to select? We can support you with that. Once the study design is finalized, we can also use that same expertise to support its implementation. With our ability to quickly establish new collaborations, in addition to utilizing existing ones, we are able to swiftly implement novel and enormously complex Phase I type studies. These studies often engage the support of experts across multiple disciplines, coupled with access to related diagnostics. The capability to pull in resources allows studies to be implemented in a Phase I environment. Sometimes it’s hard to imagine such studies could be readily implemented elsewhere and are frequently too intensive or complex to conduct within individual clinics in a multi-center approach.
Multiple Disciplines
Realization of a 90 subject healthy volunteer study employing expertise and technology across the four disciplines of neurology, ophthalmology, dermatology and specialist coagulation laboratory
Direct collaboration with Charité - Universitätsmedizin Berlin, Europe’s leading University Hospital
Established partnerships with genuine world opinion leaders in fields such as Rheumatology, Immunology and Neurology
Access to specific therapeutic area expertise from over 100 clinics and institutes
In-house expertise in disciplines including clinical pharmacology, internal medicine, respiratory disease, cardiovascular disease and regulatory affairs